All Stories

  1. KSHV infection of endothelial precursor cells with lymphatic characteristics as a novel model for translational Kaposi’s sarcoma studies
  2. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells
  3. KSHV requires vCyclin to overcome replicative senescence in primary human lymphatic endothelial cells
  4. Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells
  5. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication
  6. Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism
  7. Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection
  8. Isolation and characterization of circulating lymphatic endothelial colony forming cells
  9. Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival
  10. Viral activation of cellular metabolism
  11. KSHV-TK: thymidine kinase or tyrosine kinase?
  12. Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation
  13. Dengue Virus Induces and Requires Glycolysis for Optimal Replication
  14. Kaposi's Sarcoma-Associated Herpesvirus Downregulates Transforming Growth Factor  2 To Promote Enhanced Stability of Capillary-Like Tube Formation
  15. Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions
  16. Vaccinia Virus Requires Glutamine but Not Glucose for Efficient Replication
  17. Ets-1 Is Required for the Activation of VEGFR3 during Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells
  18. Global Metabolic Profiling of Infection by an Oncogenic Virus: KSHV Induces and Requires Lipogenesis for Survival of Latent Infection
  19. The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation
  20. ANGIOGENIC AND ONCOGENIC ALTERATIONS OF ENDOTHELIAL CELLS BY KSHV
  21. KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes
  22. Latent KSHV Infection of Endothelial Cells Induces Integrin Beta3 to Activate Angiogenic Phenotypes
  23. The HIV Protease Inhibitor Nelfinavir Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication In Vitro
  24. Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells
  25. Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells
  26. CD8 T Cell Control of HSV Reactivation from Latency Is Abrogated by Viral Inhibition of MHC Class I
  27. The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells
  28. Persistent Activation of STAT3 by Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells
  29. The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma
  30. Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells Activates Hypoxia-Induced Factors
  31. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation
  32. INHIBITION OF APOPTOSIS BY THE γ-HERPESVIRUSES
  33. Synthesis and studies of cis-Mo(CO)2(L–L′)2 and Mo(L–L′)3 complexes of 2-(phenylazo)pyridines (L–L′) and the crystal structures of Mo(CO)2(4-methyl-2-(phenylazo)pyridine)2 and Mo(4-methyl-2-(phenylazo)pyridine)3
  34. De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells
  35. Immunoreceptor Tyrosine-Based Activation Motif-Dependent Signaling by Kaposi's Sarcoma-Associated Herpesvirus K1 Protein: Effects on Lytic Viral Replication
  36. Herpes Simplex Virus 1 Open Reading Frames O and P Are Not Necessary for Establishment of Latent Infection in Mice
  37. Deregulated signal transduction by the K1 gene product of Kaposi’s sarcoma-associated herpesvirus
  38. EXPRESSION OF LATENT HHV-8 GENES
  39. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
  40. The product of ORF O located within the domain of herpes simplex virus 1 genome transcribed during latent infection binds to and inhibits in vitro binding of infected cell protein 4 to its cognate DNA site
  41. The Structure and Coding Organization of the Genomic Termini of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8)